ACE applications are now open through October 15. Join a national network committed to providing high-quality, comprehensive Ataxia care. Apply Now!
SCA3 FDA Patient-Led Listening Session Summary READ FULL REPORT EL-PFDD MEETING ON ATAXIA GENERAL INFORMATION ABOUT SCA3 On September 22, 2023, the FDA hosted a listening session with advocates from Read More…
SCA3/MJD A collection of resources for individuals and families affected by Spinocerebellar Ataxia Type 3 (SCA3), also known as Machado-Joseph Disease (MJD). WEBINARS RESEARCH PIPELINE INFORMATION RESEARCH NEWS BECOME A Read More…
SCA3 Treatment Pipeline Tracking progress of the development of SCA3 therapies. Pipeline for SCA3 This is a visual tool created to show the progress of SCA3 therapies that are currently Read More…
